Healix

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a Physician Office Infusion Center (POIC)

Authors:
Ramesh V. Nathan, MD, FIDSA – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA

Brian Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX
Jorge R. Bernett, MD – Infectious Disease Doctors Medical Group, Walnut Creek, CA
Richard C. Prokesch, MD, FACP, FIDSA – Infectious Disease Associates, Riverdale, GA
Quyen Luu, MD – Quyen Luu, MD, Macon, GA
Kimberly A. Couch, PharmD, MA, FIDSA, FASHP – Healix Infusion Therapy, Inc., Sugar Land, TX
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound